Torigen Pharmaceuticals Inks National Distribution Deal with MWI Animal Health

FARMINGTON, CONN. (PRWEB) JUNE 22, 2022

Torigen Pharmaceuticals, Inc, a commercial-stage animal health biologics company, announced today that it has entered into a national distribution agreement with MWI Animal Health, a leading distributor of animal health products and services and a subsidiary of AmerisourceBergen. The agreement will expand access to Torigen’s experimental autologous cancer vaccine for companion animals.

This is the first national distribution deal for Torigen whose experimental autologous cancer vaccine uses an animal’s tumor cells to stimulate the pet’s immune system to fight cancer. Torigen’s autologous prescription product is regulated by the USDA Center of Veterinary Biologics under 9 CFR 103.3.

MWI, the premier distributor for both private- and corporate-owned veterinary clinics, will support the distribution of the tumor collection kits to veterinarians across the country through its national distribution network. Through its network of 18 distribution centers in key markets nationwide, the company can support same-day or overnight deliveries to communities across the country.

Read the full news release here>>